SIMILAR SVR RATES IN IL28B CC, CT OR TT PRIOR RELAPSER, PARTIAL- OR NULL-RESPONDER PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN: RETROSPECTIVE ANALYSIS OF THE REALIZE STUDY

被引：44

作者：

Pol, S. ^{[1
,2
]}

Aerssens, J. ^{[3
]}

Zeuzem, S. ^{[4
]}

Andreone, P. ^{[5
]}

Lawitz, E. J. ^{[6
]}

Roberts, S. ^{[7
]}

Younossi, Z. ^{[8
]}

Foster, G. R. ^{[9
]}

Focaccia, R. ^{[10
]}

Horban, A. ^{[11
]}

Pockros, P. J. ^{[12
,13
]}

Van Heeswijk, R.

de Meyer, S. ^{[3
]}

Luo, D. ^{[14
]}

Botfield, M. ^{[15
]}

Beumont, M. ^{[3
]}

Picchio, G. ^{[14
]}

机构：

[1] Univ Paris 05, INSERM, U567, Paris, France

[2] Cochin Hosp, AP HP, Paris, France

[3] Tibotec BVBA, Beerse, Belgium

[4] Goethe Univ Frankfurt, Med Ctr, Frankfurt, Germany

[5] Univ Bologna, Bologna, Italy

[6] Alamo Med Res Ltd, San Antonio, TX USA

[7] Alfred Hosp, Dept Gastroenterol, Melbourne, Vic, Australia

[8] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA

[9] Queen Mary Univ London, Inst Cell & Mol Sci, London, England

[10] Emilio Ribas Infect Dis Inst, Sao Paulo, Brazil

[11] Med Univ Warsaw, Warsaw, Poland

[12] Scripps Clin, La Jolla, CA USA

[13] Scripps Res Inst, La Jolla, CA 92037 USA

[14] Tibotec Inc, Titusville, NJ USA

[15] Vertex Pharmaceut Inc, Cambridge, MA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(11)60015-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S6 / S7

页数：2